» Articles » PMID: 35487848

Antibacterial Contact-dependent Proteins Secreted by Gram-negative Cystic Fibrosis Respiratory Pathogens

Overview
Date 2022 Apr 29
PMID 35487848
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is a genetic disease that affects almost 100 000 people worldwide. CF patients suffer from chronic bacterial airway infections that are often polymicrobial and are the leading cause of mortality. Interactions between pathogens modulate expression of genes responsible for virulence and antibiotic resistance. One of the ways bacteria can interact is through contact-dependent systems, which secrete antibacterial proteins (effectors) that confer advantages to cells that harbor them. Here, we highlight recent work that describes effectors used by Gram-negative CF pathogens to eliminate competitor bacteria. Understanding the mechanisms of secreted effectors may lead to novel insights into the ecology of bacteria that colonize respiratory tracts and could also pave the way for the design of new therapeutics.

Citing Articles

The dominant lineage of an emerging pathogen harbours contact-dependent inhibition systems.

Crisan C, Goldberg J Microb Genom. 2025; 11(1).

PMID: 39853206 PMC: 11893273. DOI: 10.1099/mgen.0.001332.


Antibacterial potential of complex cystic fibrosis isolates.

Crisan C, Pettis M, Goldberg J mSphere. 2024; 9(7):e0033524.

PMID: 38980073 PMC: 11288042. DOI: 10.1128/msphere.00335-24.


The type II secretion system as an underappreciated and understudied mediator of interbacterial antagonism.

Cianciotto N Infect Immun. 2024; 92(8):e0020724.

PMID: 38980047 PMC: 11320942. DOI: 10.1128/iai.00207-24.


Bactericidal effectors of the type IV secretion system: functional definition of the nuclease TfdA and structural determination of TfcB.

Cobe B, Dey S, Minasov G, Inniss N, Satchell K, Cianciotto N mBio. 2024; 15(7):e0119824.

PMID: 38832773 PMC: 11253643. DOI: 10.1128/mbio.01198-24.


virulence: a current view.

Mikhailovich V, Heydarov R, Zimenkov D, Chebotar I Front Microbiol. 2024; 15:1385631.

PMID: 38741741 PMC: 11089167. DOI: 10.3389/fmicb.2024.1385631.


References
1.
Fast D, Kostiuk B, Foley E, Pukatzki S . Commensal pathogen competition impacts host viability. Proc Natl Acad Sci U S A. 2018; 115(27):7099-7104. PMC: 6142279. DOI: 10.1073/pnas.1802165115. View

2.
Burkinshaw B, Liang X, Wong M, Le A, Lam L, Dong T . A type VI secretion system effector delivery mechanism dependent on PAAR and a chaperone-co-chaperone complex. Nat Microbiol. 2018; 3(5):632-640. DOI: 10.1038/s41564-018-0144-4. View

3.
Crisan C, Nichols H, Wiesenfeld S, Steinbach G, Yunker P, Hammer B . Glucose confers protection to Escherichia coli against contact killing by Vibrio cholerae. Sci Rep. 2021; 11(1):2935. PMC: 7858629. DOI: 10.1038/s41598-021-81813-4. View

4.
Brooke J . Advances in the Microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev. 2021; 34(3):e0003019. PMC: 8262804. DOI: 10.1128/CMR.00030-19. View

5.
Wood T, Howard S, Forster A, Nolan L, Manoli E, Bullen N . The Pseudomonas aeruginosa T6SS Delivers a Periplasmic Toxin that Disrupts Bacterial Cell Morphology. Cell Rep. 2019; 29(1):187-201.e7. PMC: 6899460. DOI: 10.1016/j.celrep.2019.08.094. View